Last Updated: August 9, 2026

GEN-XENE Drug Patent Profile

Name: GEN-XENE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Gen-xene, and what generic alternatives are available?

Gen-xene is a drug marketed by Alra and is included in three NDAs.

The generic ingredient in GEN-XENE is clorazepate dipotassium. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Gen-xene

A generic version of GEN-XENE was approved as clorazepate dipotassium by AUROBINDO PHARMA on July 17^th, 1987.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for GEN-XENE?
What are the global sales for GEN-XENE?
What is Average Wholesale Price for GEN-XENE?

Summary for GEN-XENE

US Patents:	0
Applicants:	1
NDAs:	3
Raw Ingredient (Bulk) Api Vendors:	10
Patent Applications:	4,467
DailyMed Link:	GEN-XENE at DailyMed

Drug patent expirations by year for GEN-XENE

US Patents and Regulatory Information for GEN-XENE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alra	GEN-XENE	clorazepate dipotassium	TABLET;ORAL	071787-001	Apr 26, 1988		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Alra	GEN-XENE	clorazepate dipotassium	TABLET;ORAL	071788-001	Apr 26, 1988		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Alra	GEN-XENE	clorazepate dipotassium	TABLET;ORAL	071789-001	Apr 26, 1988		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.